HSPA5 and B-cell chronic lymphocytic leukemia: Next, we investigated the mechanisms of action of ONC‐212 in CLL cells by examining changes in the expression of the mitochondrial protease CIpP, ATF4 and Grp78, and the tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL), by immunoblotting.